Chromosome missegregation causes colon cancer by APC loss of heterozygosity.
A longstanding hypothesis in the field of cancer biology is that aneuploidy causes cancer by promoting loss of chromosomes that contain tumor suppressor genes. By crossing aneuploidyprone Bub1 hypomorphic mice onto a heterozygous null background for p53, we provided conclusive evidence for this idea.(1) Surprisingly, the tumors that developed in this model had not just lost the chromosome 11 copy harboring wild-type p53, but had also gained an extra copy of chromosome 11 bearing the p53 null allele. Here we report that a similar chromosome-reshuffling blueprint drives colonic tumorigenesis in Bub1 hypomorphic mice that are heterozygous for Apc(Min), but now involving chromosome 18. These extended studies highlight that in order for whole chromosome instability to drive tumorigenesis, it needs to establish tumor suppressor gene loss of heterozygosity while retaining two copies of the other genes on the chromosome. Additional restrictions seem to apply to whole chromosome instability as a cancer causing mechanism, which will be discussed in this paper.
Baker
Darren J
DJ
Departments of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
van Deursen
Jan M
JM
D000782:Aneuploidy; D000818:Animals; D043171:Chromosomal Instability; D020090:Chromosome Segregation; D003110:Colonic Neoplasms / Q000235:genetics*; D017491:Genes, APC; D006579:Heterozygote; D019656:Loss of Heterozygosity; D051379:Mice; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000235:genetics
D016159:Tumor Suppressor Protein p53; C584281:Bub1 protein, mouse; C090464:Bub1 spindle checkpoint protein; D017346:Protein Serine-Threonine Kinases
Sci Am. 2007 May;296(5):52-9
17500414
Cancer Cell. 2007 Jan;11(1):25-36
17189716
Nature. 1992 Sep 24;359(6393):295-300
1406933
Oncogene. 1994 Apr;9(4):1021-7
8134105
J Cell Biol. 2009 Jun 15;185(6):935-7
19528293
Science. 2008 Oct 31;322(5902):703-9
18974345
EMBO J. 2005 Apr 20;24(8):1621-33
15933723
Cancer Res. 2007 Jan 1;67(1):160-6
17210695
Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1563-8
9990064
Cell Cycle. 2006 Feb;5(4):366-70
16479161
J Cell Biol. 2007 Oct 22;179(2):255-67
17938250
Mol Endocrinol. 2001 Nov;15(11):1870-9
11682618
Curr Biol. 1994 Jan 1;4(1):1-7
7922305
J Cell Biol. 2006 Feb 13;172(4):529-40
16476774
Cell Cycle. 2003 May-Jun;2(3):202-10
12734426
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16719-24
18940925
J Cell Biol. 2003 Feb 3;160(3):341-53
12551952
Semin Cancer Biol. 2005 Feb;15(1):43-9
15613287
Curr Biol. 2003 Nov 11;13(22):1979-84
14614824
Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4365-70
15767571
Trends Genet. 2008 Sep;24(9):457-66
18675487
Cancer Cell. 2009 Dec 8;16(6):475-86
19962666
Cancer Res. 2007 Nov 1;67(21):10103-5
17974949
Nat Rev Mol Cell Biol. 2009 Jul;10(7):478-87
19546858
J Cell Sci. 2008 Jan;121 Suppl 1:1-84
18089652
Nat Rev Cancer. 2010 Feb;10(2):102-15
20094045
Anticancer Res. 1999 Nov-Dec;19(6A):4887-906
10697602
Cell Cycle. 2005 Sep;4(9):1171-5
16082216
Curr Opin Cell Biol. 2005 Dec;17(6):583-9
16226453
Cancer Cell. 2009 Dec 8;16(6):451-2
19962661
Nat Genet. 2004 Jul;36(7):744-9
15208629
Nat Genet. 2006 Sep;38(9):1043-8
16921376
Cancer Cell. 2007 Jan;11(1):9-23
17189715
Dev Cell. 2007 Oct;13(4):566-79
17925231
Nature. 2001 Jan 18;409(6818):355-9
11201745
Genetics. 2008 Jun;179(2):737-46
18558649
Science. 2007 Aug 17;317(5840):916-24
17702937